Bolt Biotherapeutics, Inc.
NASDAQ:BOLT
0.6513 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.275 | 5.274 | 2.089 | 2.528 | 1.433 | 1.826 | 1.411 | 2.112 | 1.393 | 0.813 | 0.508 | 0.752 | 0 | 0 | 0 | 0 | 0.067 | 0.164 | 0.065 | 0.121 | 0.015 | 0.015 |
| Cost of Revenue
| 0.457 | 0.458 | 0.497 | 0.462 | 1.189 | 1.186 | 1.167 | 18.973 | 18.92 | 1.528 | 0.905 | 19.337 | 0.9 | 0.802 | 14.864 | 9.54 | 9.166 | 6.787 | 7.435 | 6.238 | 6.165 | 6.165 |
| Gross Profit
| 0.818 | 4.816 | 1.592 | 2.066 | 0.244 | 0.64 | 0.244 | -16.861 | -17.527 | -0.715 | -0.397 | -18.585 | -0.9 | -0.802 | -14.864 | -9.54 | -9.099 | -6.623 | -7.37 | -6.117 | -6.15 | -6.15 |
| Gross Profit Ratio
| 0.642 | 0.913 | 0.762 | 0.817 | 0.17 | 0.35 | 0.173 | -7.983 | -12.582 | -0.879 | -0.781 | -24.714 | 0 | 0 | 0 | 0 | -135.806 | -40.384 | -113.385 | -50.554 | -424.138 | -424.138 |
| Reseach & Development Expenses
| 14.976 | 16.071 | 15.825 | 14.951 | 15.644 | 14.625 | 16.845 | 18.973 | 18.92 | 18.385 | 22.484 | 19.337 | 19.707 | 14.127 | 14.864 | 9.54 | 9.166 | 6.787 | 7.435 | 6.238 | 6.165 | 6.165 |
| General & Administrative Expenses
| 4.874 | 5.837 | 5.533 | 5.76 | 5.621 | 5.616 | 5.606 | 5.485 | 5.532 | 6.304 | 5.099 | 4.941 | 4.054 | 4.299 | 2.058 | 2.865 | 2.011 | 2.122 | 2.137 | 1.3 | 0.873 | 0.873 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.874 | 5.837 | 5.533 | 5.76 | 5.621 | 5.616 | 5.606 | 5.485 | 5.532 | 6.304 | 5.099 | 4.941 | 4.054 | 4.299 | 2.058 | 2.865 | 2.011 | 2.122 | 2.137 | 1.3 | 0.873 | 0.873 |
| Other Expenses
| 3.565 | 4.675 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.084 | -14.125 | 2.38 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 19.85 | 21.908 | 21.358 | 20.711 | 21.265 | 20.241 | 22.451 | 24.458 | 24.452 | 24.689 | 27.583 | 24.278 | 23.761 | 18.426 | 16.922 | 12.405 | 11.177 | 8.909 | 9.572 | 1.299 | 0.894 | 0.894 |
| Operating Income
| -19.032 | -17.092 | -19.766 | -18.183 | -19.832 | -18.415 | -21.04 | -22.346 | -23.059 | -23.876 | -27.075 | -23.526 | -23.761 | -18.426 | -16.922 | -12.405 | -11.11 | -8.745 | -9.507 | -7.417 | -7.023 | -7.023 |
| Operating Income Ratio
| -14.927 | -3.241 | -9.462 | -7.193 | -13.839 | -10.085 | -14.911 | -10.58 | -16.553 | -29.368 | -53.297 | -31.285 | 0 | 0 | 0 | 0 | -165.821 | -53.323 | -146.262 | -61.298 | -484.31 | -484.31 |
| Total Other Income Expenses Net
| -2.163 | 6.281 | 1.863 | 1.926 | 1.775 | 1.435 | 1.043 | 0.587 | 0.395 | 0.198 | -0.082 | 0.131 | 0.176 | -6.084 | -14.125 | 2.38 | 0.051 | 0.112 | 0.145 | 0.233 | 0.052 | 0.052 |
| Income Before Tax
| -21.195 | -10.811 | -17.903 | -16.257 | -18.057 | -16.98 | -19.997 | -21.759 | -22.664 | -23.678 | -27.157 | -23.395 | -23.585 | -24.454 | -31.035 | -10.001 | -11.059 | -8.633 | -9.362 | -7.184 | -6.971 | -6.971 |
| Income Before Tax Ratio
| -16.624 | -2.05 | -8.57 | -6.431 | -12.601 | -9.299 | -14.172 | -10.303 | -16.27 | -29.124 | -53.459 | -31.11 | 0 | 0 | 0 | 0 | -165.06 | -52.64 | -144.031 | -59.372 | -480.724 | -480.724 |
| Income Tax Expense
| 0 | 0.415 | 1.897 | -0.462 | 0.336 | -1.435 | -1.043 | 0 | -0.395 | -0.198 | -0.361 | -0.761 | -0.644 | 6.028 | 13.892 | -2.404 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -21.195 | -10.811 | -17.903 | -16.257 | -18.057 | -15.545 | -18.954 | -21.759 | -22.269 | -23.48 | -27.157 | -23.395 | -23.585 | -24.454 | -31.035 | -10.001 | -11.059 | -8.633 | -9.362 | -7.184 | -6.971 | -6.971 |
| Net Income Ratio
| -16.624 | -2.05 | -8.57 | -6.431 | -12.601 | -8.513 | -13.433 | -10.303 | -15.986 | -28.881 | -53.459 | -31.11 | 0 | 0 | 0 | 0 | -165.06 | -52.64 | -144.031 | -59.372 | -480.724 | -480.724 |
| EPS
| -0.56 | -0.28 | -0.47 | -0.43 | -0.48 | -0.41 | -0.5 | -0.58 | -0.6 | -0.63 | -0.73 | -0.63 | -0.64 | -1.14 | -0.97 | -0.71 | -0.79 | -0.62 | -0.67 | -3.54 | -3.59 | -3.59 |
| EPS Diluted
| -0.56 | -0.28 | -0.47 | -0.43 | -0.48 | -0.41 | -0.5 | -0.58 | -0.6 | -0.63 | -0.73 | -0.63 | -0.64 | -1.14 | -0.97 | -0.71 | -0.79 | -0.62 | -0.67 | -3.54 | -3.59 | -3.59 |
| EBITDA
| -18.575 | -16.634 | -19.269 | -18.183 | -19.374 | -17.948 | -21.04 | -21.907 | -22.651 | -23.519 | -27.075 | -23.222 | -23.505 | -12.07 | -2.797 | -14.606 | -11 | -8.644 | -9.411 | -7.332 | -6.946 | -6.946 |
| EBITDA Ratio
| -14.569 | -3.154 | -9.224 | -7.193 | -13.52 | -9.829 | -14.911 | -10.373 | -16.261 | -28.929 | -53.297 | -30.88 | 0 | 0 | 0 | 0 | -164.179 | -52.707 | -144.785 | -60.595 | -479 | -479 |